Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A critical analysis of SURMOUNT-4's enrollment biases, follow-up duration, generalizability gaps, statistical caveats, and conflict-of-interest considerations for tirzepatide weight maintenance.
Read clinical reviewA detailed breakdown of the SURMOUNT-4 trial design, randomized withdrawal methodology, estimand framework, and statistical choices that shaped tirzepatide's weight-regain data.
Read clinical reviewHealth-economic analysis of tirzepatide continuation vs discontinuation from SURMOUNT-4, including cost per QALY estimates, payer coverage dynamics, and individual value calculations.
Read clinical reviewDeep-dive into SURMOUNT-4 follow-up findings on tirzepatide weight regain after discontinuation, durability of effect, and long-term safety signals from the 2024 JAMA trial.
Read clinical reviewDeep-dive into SURMOUNT-4 pre-specified and post-hoc subgroup analyses for tirzepatide weight maintenance, examining differential responses by age, sex, BMI, race, and baseline biomarkers.
Read clinical reviewDeep-dive into SURMOUNT-4's clinical implications for tirzepatide prescribing: weight regain data, guideline updates, and what the trial means for real-world patients.
Read clinical review